Skip Navigation
Megan McArdle

Megan McArdle - Megan McArdle is a senior editor for The Atlantic who writes about business and economics. She has worked at three start-ups, a consulting firm, an investment bank, a disaster recovery firm at Ground Zero, and The Economist. She is currently on leave.
More

Megan was born and raised on the Upper West Side of Manhattan, and yes, she does enjoy her lattes, as well as the occasional extra-dry skim-milk cappuccino. Her checkered work history includes three start-ups, four years as a technology project manager for a boutique consulting firm, a summer as an associate at an investment bank, and a year spent as sort of an executive copy girl for one of the disaster-recovery firms at Ground Zero � all before the age of 30.

While working at Ground Zero, Megan started Live From the WTC, a blog focused on economics, business, and cooking. She may or may not have been the first major economics blogger, depending on whether we are allowed to throw outlying variables such as Brad Delong out of the set. From there it was but a few steps down the slippery slope to freelance journalism. She has worked in various capacities for The Economist, where she wrote about economics and oversaw the founding of Free Exchange, the magazine's economics blog. She has also maintained her own blog, Asymmetrical Information, which moved to The Atlantic, along with its owner, in August 2007.

Megan holds a bachelor's degree in English literature from the University of Pennsylvania and an M.B.A. from the University of Chicago. After a lifetime as a New Yorker, she now resides in northwest Washington, D.C., where she is still trying to figure out what one does with an apartment larger than 400 square feet.

How Bad Are Hospital Acquired Infections in America?

By Megan McArdle
Sep 1 2011, 3:02 PM ET Comment

Yesterday, I saw this graphic linked by Kevin Drum, purporting to show that the US hospitals are killing their patients in horrifying numbers:


The Hazards of Hospitals

The thing set off huge alarm bells.  Not because I think that it's impossible that US hospitals are dropping the ball on hospital acquired infections--indeed, my column next month, which is already at the printers, will be on antibiotic resistance.  And hospital procedures like hand-washing play a huge role in the spread of resistant infection.


But these numbers were wildly out-of-sync with the ones I'd seen.  While some European nations have made really admirable progress on hospital acquired infections (the Netherlands, for example, seems to have virtually eliminated MRSA through strict isolation procedures), others are as bad or worse.  What makes a country's health care system vulnerable to hospital acquired infections or other iatrogenic deaths is not how their health care is financed; it's a large number of idiosyncratic differences in hospital procedure, treatment guidelines, and drug distribution.

So I started looking at the links, which (at least the ones I looked at) didn't say what they were purported to say; for example, the graphic says that the US ranks last out of 19 countries in preventable deaths at hospitals, but the source seems to be a Commonwealth Fund report that ranks the US last in "amenable death", which basically includes any death that could have been prevented by more "timely and effective healthcare".

I was going to write all this up . . . but Kevin beat me to it:

I guess it was too good to check, so I didn't check it. But a reader emailed this morning to suggest that this was preposterous, and he seems to be right. I checked the references at the bottom of the MBCC chart, and none of them seemed to back up their numbers. What's more, a few years ago the CDC estimated 99,000 deaths per year out of 1.7 million HAIs, a mortality rate of 5.8%. For the EU, the European Centre for Disease Prevention and Control estimates 146,000 deaths per year out of 4.5 million HAIs (see p. 27), a mortality rate of 3.3%.

That's a modest difference, and it gets even more modest when you read more about these estimates, which are very, very rough and depend strongly on exactly how you count infections and how you attribute deaths. You can read much more about it in this WHO report if you're interested. The chart below, from the WHO report (with U.S. figures added from here), shows HAI prevalence rates in various high-income countries, and on this score the U.S. does pretty well. Most likely, the U.S. is about average both in prevalence of HAI and in mortality rates from HAI. Apologies for the error.

The problem of hospital acquired infection is quite bad enough without inflating it to ludicrous proportions. I have no idea why medicalbillingandcodingcertification.net wants to turn a collection of deliberate half-truths into an infographic, but they ought to be ashamed of themselves.

Presented by

More at The Atlantic

For the St. Louis Art Museum, a Legal Victory Raises Ethical Questions St. Louis Museum's Legal Victory Raises Ethical Questions
The Edwards Trial: A Bad Idea From Before the Start The Edwards Trial: A Massive Waste of Time
Study of the Day: A Diet Loaded With sugar Makes Rats Dumber Study: Sugary Diets
May Dumb You Down
Why Do Asian Americans Have the Worst Long-Term Unemployment? Why Asian-Americans Have the Worst Long-Term Joblessness
The Rock-Mining Children of Sierra Leone Have Not Found Peace 10 Years After Civil War, No Peace for Sierra Leone's Kids

Join the Discussion

After you comment, click Post. If you’re not already logged in you will be asked to log in or register.
blog comments powered by Disqus
View All Correspondents

The Biggest Story in Photos

The Unreal World

May 31, 2012

Subscribe Now

SAVE 59%! 10 issues JUST $2.45 PER COPY

Facebook

Newsletters

Sign up to receive our free newsletters

(sample)

(sample)

(sample)

(sample)

(sample)

(sample)

Megan McArdle
from the Magazine

Why You Can’t Get a Taxi

And how an upstart company may change that

Europe’s Real Crisis

The Continent’s problems are as much demographic as financial. They won’t go away soon.

Why Companies Fail

GM’s stock price has sunk by a third since its IPO. Why is corporate turnaround so difficult…